TY - JOUR
T1 - KCNA4 deficiency leads to a syndrome of abnormal striatum, congenital cataract and intellectual disability
AU - Kaya, Namik
AU - Alsagob, Maysoon
AU - D'Adamo, Maria Cristina
AU - Al-Bakheet, Albandary
AU - Hasan, Sonia
AU - Muccioli, Maria
AU - Almutairi, Faten B.
AU - Almass, Rawan
AU - Aldosary, Mazhor
AU - Monies, Dorota
AU - Mustafa, Osama M.
AU - Alyounes, Banan
AU - Kenana, Rosan
AU - Al-Zahrani, Jawaher
AU - Naim, Eva
AU - Binhumaid, Faisal S.
AU - Qari, Alya
AU - Almutairi, Fatema
AU - Meyer, Brian
AU - Plageman, Timothy F.
AU - Pessia, Mauro
AU - Colak, Dilek
AU - Al-Owain, Mohammed
N1 - Funding Information:
This research was conducted through intramural funds provided by King Faisal Specialist Hospital and Research Centre (KFSHRC-RAC: 2120022) and National Plan for Science, Technology and Innovation Programme under King Abdulaziz City for Science and Technology (NSTIP/KACST) for supporting NK (11-BIO2221-20) and DC (11-BIO2072-20).
PY - 2016/11/1
Y1 - 2016/11/1
N2 - Background Voltage-gated potassium channels are highly diverse proteins representing the most complex class of voltage-gated ion channels from structural and functional perspectives. Deficiency of these channels usually results in various human disorders. Objectives To describe a novel autosomal recessive syndrome associated with KCNA4 deficiency leading to congenital cataract, abnormal striatum, intellectual disability and attention deficit hyperactivity disorder. Methods We used SNP arrays, linkage analyses, autozygosity mapping, whole-exome sequencing, RT-PCR and two-electrode voltage-clamp recording. Results We identified a missense variant (p. Arg89Gln) in KCNA4 in four patients from a consanguineous family manifesting a novel syndrome of congenital cataract, abnormal striatum, intellectual disability and attention deficit hyperactivity disorder. The variant was fully segregated with the disease and absent in 747 ethnically matched exomes. Xenopus oocytes were injected with human Kv1.4 wild-type mRNA, R89Q and WT/R89Q channels. The wild type had mean current amplitude that was significantly greater than those recorded from the cells expressing the same amount of mutant mRNA. Co-expression of the wild type and mutant mRNAs resulted in mean current amplitude that was significantly different from that of the wild type. RTPCR indicated that KCNA4 is present in mouse brain, lens and retina. KCNA4 interacts with several molecules including synaptotagmin I, DLG1 and DLG2. The channel co-localises with cholinergic amacrine and rod bipolar cells in rats and is widely distributed in the central nervous system. Based on previous studies, the channel is highly expressed in outer retina, rod inner segments, hippocampus and concentrated in axonal membranes. Conclusion KCNA4 (Kv1.4) is implicated in a novel syndrome characterised by striatal thinning, congenital cataract and attention deficit hyperactivity disorder. Our study highlights potassium channels' role in ocular and neuronal genetics.
AB - Background Voltage-gated potassium channels are highly diverse proteins representing the most complex class of voltage-gated ion channels from structural and functional perspectives. Deficiency of these channels usually results in various human disorders. Objectives To describe a novel autosomal recessive syndrome associated with KCNA4 deficiency leading to congenital cataract, abnormal striatum, intellectual disability and attention deficit hyperactivity disorder. Methods We used SNP arrays, linkage analyses, autozygosity mapping, whole-exome sequencing, RT-PCR and two-electrode voltage-clamp recording. Results We identified a missense variant (p. Arg89Gln) in KCNA4 in four patients from a consanguineous family manifesting a novel syndrome of congenital cataract, abnormal striatum, intellectual disability and attention deficit hyperactivity disorder. The variant was fully segregated with the disease and absent in 747 ethnically matched exomes. Xenopus oocytes were injected with human Kv1.4 wild-type mRNA, R89Q and WT/R89Q channels. The wild type had mean current amplitude that was significantly greater than those recorded from the cells expressing the same amount of mutant mRNA. Co-expression of the wild type and mutant mRNAs resulted in mean current amplitude that was significantly different from that of the wild type. RTPCR indicated that KCNA4 is present in mouse brain, lens and retina. KCNA4 interacts with several molecules including synaptotagmin I, DLG1 and DLG2. The channel co-localises with cholinergic amacrine and rod bipolar cells in rats and is widely distributed in the central nervous system. Based on previous studies, the channel is highly expressed in outer retina, rod inner segments, hippocampus and concentrated in axonal membranes. Conclusion KCNA4 (Kv1.4) is implicated in a novel syndrome characterised by striatal thinning, congenital cataract and attention deficit hyperactivity disorder. Our study highlights potassium channels' role in ocular and neuronal genetics.
UR - http://www.scopus.com/inward/record.url?scp=84984985042&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84984985042&partnerID=8YFLogxK
U2 - 10.1136/jmedgenet-2015-103637
DO - 10.1136/jmedgenet-2015-103637
M3 - Article
AN - SCOPUS:84984985042
SN - 0022-2593
VL - 53
SP - 786
EP - 792
JO - Journal of medical genetics
JF - Journal of medical genetics
IS - 11
ER -